Login / Signup

Cradle-to-Grave Emission Reduction for Easyhaler Dry Powder Inhaler Product Portfolio.

Matleena IngetHanna Hisinger-MölkänenMyles HowardSatu LähelmäNoora Paronen
Published in: Pulmonary therapy (2023)
Our results show that the climate impact of pharmaceutical products can be reduced without making changes to the product itself. The CF of Easyhaler products is in agreement with the lower end of the CF range previously reported for dry powder inhalers. Climate impact from the protective cover was one-tenth compared to the climate impact from the product itself.
Keyphrases
  • climate change
  • cystic fibrosis